
Global X Genomics & Biotechnology ETF
GNOM institutional ownership changes in Q2 2026: 8 institutions opened or added positions, 9 trimmed or exited. GNOM (Global X Genomics & Biotechnology ETF) is held by 21 institutional investors as of Q2 2026. Top institutional shareholders: Bank of America Corp. ($6.4M), Sumitomo Mitsui Trust Group, Inc. ($5.3M), Susquehanna International Group, LLP ($2.3M). Institutions were selling, on balance.
Who's Trading
Source dates: Price Nov 6, 2026 · Insiders none · Activists none · Congress none
No recent insider, activist, or congressional trades for GNOM.
Top Holders
Showing 1-20 of 22
Continue exploring
Similar stocks
Questions investors ask about GNOM
Who owns GNOM?
21 institutional investors held GNOM on June 30, 2026, led by Bank of America Corp. ($6.4M), Sumitomo Mitsui Trust Group, Inc. ($5.3M) and Susquehanna International Group, LLP ($2.3M).
How many hedge funds hold GNOM?
21 institutional investors reported GNOM in their 13F filings for the quarter ended June 30, 2026, $19.4M in all. 2 of them are rated Elite.
Are institutions buying or selling GNOM?
Selling, on balance. In Q2 2026, 9 institutions trimmed or exited GNOM and 8 institutions opened or added to positions.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer